These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24086492)

  • 1. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS.
    Das MK; Bishwal SC; Das A; Dabral D; Varshney A; Badireddy VK; Nanda R
    Anal Chem; 2014 Jan; 86(2):1229-37. PubMed ID: 24350824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.
    Hewitt MJ; Belluomo I; Zuffa S; Boshier PR; Myridakis A
    Sci Rep; 2022 Sep; 12(1):15887. PubMed ID: 36151300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method for the collection and assay of volatile organic compounds in breath.
    Phillips M
    Anal Biochem; 1997 May; 247(2):272-8. PubMed ID: 9177688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Two-Dimensional Gas Chromatography-Mass Spectrometry Analysis of Exhaled Breath Compounds after Whole Grain Diets.
    Raninen K; Nenonen R; Järvelä-Reijonen E; Poutanen K; Mykkänen H; Raatikainen O
    Molecules; 2021 May; 26(9):. PubMed ID: 34063191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Headspace analysis of E-cigarette fluids using comprehensive two dimensional GC×GC-TOF-MS reveals the presence of volatile and toxic compounds.
    Patel D; Taudte RV; Nizio K; Herok G; Cranfield C; Shimmon R
    J Pharm Biomed Anal; 2021 Mar; 196():113930. PubMed ID: 33581591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
    Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted volatolomics of human monocytes: Comparison of 2D-GC/TOF-MS and 1D-GC/Orbitrap-MS methods.
    Zemánková K; Pavelicová K; Pompeiano A; Mravcová L; Černý M; Bendíčková K; Hortová Kohoutková M; Dryahina K; Vaculovičová M; Frič J; Vaníčková L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1184():122975. PubMed ID: 34655893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breath metabolome of mice infected with Pseudomonas aeruginosa.
    Purcaro G; Nasir M; Franchina FA; Rees CA; Aliyeva M; Daphtary N; Wargo MJ; Lundblad LKA; Hill JE
    Metabolomics; 2019 Jan; 15(1):10. PubMed ID: 30830447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross Platform Analysis of Volatile Organic Compounds Using Selected Ion Flow Tube and Proton-Transfer-Reaction Mass Spectrometry.
    Lin GP; Vadhwana B; Belluomo I; Boshier PR; Španěl P; Hanna GB
    J Am Soc Mass Spectrom; 2021 May; 32(5):1215-1223. PubMed ID: 33831301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath gas monitoring during a glucose challenge by a combined PTR-QMS/GC×GC-TOFMS approach for the verification of potential volatile biomarkers.
    Gruber B; Keller S; Groeger T; Matuschek G; Szymczak W; Zimmermann R
    J Breath Res; 2016 Jun; 10(3):036003. PubMed ID: 27341456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of volatile biomarkers of therapeutic radiation in breath.
    Phillips M; Byrnes R; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mehta V; Mundada M; Patel U; Ramakrishna N; Schiff PB; Zhang X
    J Breath Res; 2013 Sep; 7(3):036002. PubMed ID: 23793046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.